• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CHM

CHIMERIC THERAPEUTICS LIMITED

0.00% ! 0.4¢
Market Cap $8.060M  !

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company.... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company. The Company is focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its pipeline includes CHM 1101 and CHM 2101. Its CHM 1101 (CLTX CAR-T) is a CAR-T therapy developed for the treatment of patients with solid tumors. CHM-1101 is being studied in a Phase 1B clinical trial in recurrent/ progressive glioblastoma. CHM 2101 is a third generation CDH17 CAR T, which is in preclinical development with a planned Phase I clinical trial in neuroendocrine tumors, colorectal, pancreatic and gastric cancer. Its pipeline also includes the CORE-NK platform, a clinically validated, off-the-shelf natural killer (NK) cell therapy platform to their portfolio (CHM 0201). The Company is also focused on the development of NK and CAR NK assets with plans for Phase 1B clinical trials in solid tumors and blood cancers.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CHM 09:35 30 6.2K
09:35 Last post  ThePig Comments Created with Sketch.  30  Views Created with Sketch.  6.2K 
CHM 11/06/25 27 8.5K
11/06/25 Last post  Shellbell Comments Created with Sketch.  27  Views Created with Sketch.  8.5K 
CHM
Are shareholders ready to demand change at Chimeric Therapeutics?
10/06/25 18 6.8K
TRENDING NEWS

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

NEWS
13 Jun 2025
10/06/25 Last post  shoeshineboy Comments Created with Sketch.  18  Views Created with Sketch.  6.8K 
CHM 09/06/25 78 31K
09/06/25 Last post  dalts66 Comments Created with Sketch.  78  Views Created with Sketch.  31K 
CHM 07/06/25 85 28K
07/06/25 Last post  Shellbell Comments Created with Sketch.  85  Views Created with Sketch.  28K 
CHM
Chimeric the science (valuation) explained part 6
05/06/25 3 1.5K
05/06/25 Last post  Shellbell Comments Created with Sketch.  3  Views Created with Sketch.  1.5K 
CHM 29/05/25 0 319
29/05/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  319 
CHM 28/05/25 0 479
28/05/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  479 

See All Discussions arrow Created with Sketch.

Timeline

Chimeric receives $2.5 M advance on FY25 R&D tax incentive
10 Jun 12:20
 
CHM CDH17 receives FDA Fast Track
04 Jun 09:47
 
Application for quotation of securities - CHM
29 May 16:52
 
Change in substantial holding - PH
28 May 16:15
 
Application for quotation of securities - CHM
26 May 15:26
 
Letter to Shareholders
26 May 14:05
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $15.69K 3.919M

Buyers (Bids)

No. Vol. Price($)
26 21936206 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 24685267 27
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
Last
0.5¢
  Change
0.000 ( 12.5 %)
Open High Low Volume
0.4¢ 0.5¢ 0.4¢ 900000
Last updated 15.59pm 13/06/2025 ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.